Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
385 Leser
Artikel bewerten:
(1)

Germany's BfArM Joins SNOMED International for Nationwide Use of SNOMED CT

Finanznachrichten News

LONDON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Germany's Federal Institute for Drugs and Medical Devices (BfArM) has announced their membership in SNOMED International for national use of SNOMED CT from the beginning of January 2021.

SNOMED CT, the world's most comprehensive clinical terminology and a recognized critical element for the electronic exchange of health data, is an important building block to achieve Germany's digitization initiative. Effective January 1, 2021, German users can register to request a free license for use of SNOMED CT by visiting the BfArM's National Release Centerwebsite.

BfArMPresident Prof. Dr. Karl Broich shares, "with SNOMED CT, the digitization of the healthcare system in Germany continues. As an international standardized health terminology, SNOMED CT is an important prerequisite for the reliable use and exchange of medical data from various sources to enable clinical and research activities. This is how we accelerate innovative developments and deliver new types of care options more quickly to patients."

Not all users in Germany will be new to SNOMED CT. In 2020, the Federal Ministry of Education and Researchinitiated a pilot license with a limited number of sub-licenses for Medical Informatics Initiative research participants and partners, an endeavor led by the TMF. Additionally, SNOMED International and Germany have, over the years, arranged for limited public good licenses allowing German clinicians, researchers and academics to experience the power of SNOMED CT. Now with full membership, all German institutions and specialist groups involved in the health care sector wishing to use SNOMED CT in their applications can apply for a free licensefrom the BfArM.

Founded in 2007 by nine charter nations, SNOMED International is a not-for-profit organization that owns and maintains SNOMED CT, the world's most comprehensive clinical terminology. With over 350,000 concepts, SNOMED CT is not just a coding system of diagnosis. It also covers clinical findings like signs and symptoms and tens of thousands of surgical, therapeutic and diagnostic procedures. Also within the scope of SNOMED CT are observables and those concepts representing body structures, organisms, substances, pharmaceutical products, physical objects, physical forces, specimens, etc. needed to be recorded in or around the health record.

With SNOMED CT, users can record patient data more accurately, exchange patient data both within the health care team and with patients, both locally and across borders, to improve patient outcomes. Further, SNOMED CT can be used in health data and analytics platforms for clinical analytics, population analytics, management analytics, clinical research, applied research, and other research activities to improve health care.

SNOMED International CEO Don Sweete recognizes the dedication and work Germany has committed to formally begin their SNOMED CT journey. "With our global circumstance, 2021 is a year to showcase the power delivered by digital health," Don says. "Furthering Germany's digital health goals, SNOMED International membership will enable German users nationally to take advantage of augmented content areas such as Social Care and Social Determinants of Health, Genomics, Vaccines, and Devices. Due to SNOMED CT's polyhierarchical structure, Germany will be able to leverage SNOMED CT to engage in leading edge research and data analytics."

SNOMED International is proud to now work with 22 Members across Europe, and 40 Members globally. The addition of Germany to the organization further extends the reach of interoperable patient health information across Europe and broadens mature use of SNOMED CT to support German care delivery and clinical research.

For more information, please visit SNOMED Internationalor the BfArM SNOMED CT website.

Media Contact:

Kelly Kuru
SNOMED International | Chief Communications Officer


© 2021 GlobeNewswire (Europe)
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.